chemoradiotherapy

Open Access
Tracheobronchial Adenoid Cystic Carcinoma Treated Successfully With Chemoradiotherapy Followed by Durvalumab: A Case Report
YU NAKATANI, TETSUYA KUBOTA, YOSHIAKI HIRAKAWA, TAKASHI ANAYAMA, TOMOKI KIMURA and AKIHITO YOKOYAMA

In Vivo May 2024, 38 (3) 1483-1488; DOI: https://doi.org/10.21873/invivo.13595
Open Access
Retrospective Analysis of Definitive Chemoradiotherapy With FOLFOX in Patients With Esophageal Cancer Intolerant to Cisplatin
MAYU YADA, SHUN YAMAMOTO, YOSHITAKA HONMA, HIDEKAZU HIRANO, NATSUKO OKITA, HIROKAZU SHOJI, SATORU IWASA, ATSUO TAKASHIMA, AKIHITO NAGAHARA and KEN KATO

In Vivo March 2024, 38 (2) 761-766; DOI: https://doi.org/10.21873/invivo.13499
Open Access
Negative Prognostic Impact of Smoking on Long-term Survival in Patients With Nasopharyngeal Carcinoma Treated With Curative (Chemo)radiotherapy
MILOSLAV PALA, PAVLA NOVAKOVA, TEREZA DRBOHLAVOVA, ANTONIN VRANA, ZDENKA PECHACOVA, KAROLINA VOTAVOVA, ADAM SUBRT, DANIEL KREJCI, PETRA HOLECKOVA and PETRA TESAROVA

In Vivo July 2023, 37 (4) 1775-1785; DOI: https://doi.org/10.21873/invivo.13266
Open Access
Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients
HIROYOSHI KOIDE, SATOSHI NODA, YUMI OKUNUKI, SHIGEHIRO OWAKI, TAKESHI SHIMIZU, TOMOHIRO TERADA and SHIN-YA MORITA

In Vivo September 2022, 36 (5) 2465-2472; DOI: https://doi.org/10.21873/invivo.12982
Open Access
Synchronous Anal Canal Cancer and Cervical Cancer: Report of a Case and Management Implication
CARLO GUGLIELMO CATTANEO, DANIELA MUSIO, FEDERICA TANZI, GIACOMO GUIDI, INNOCENZA PALAIA, VINCENZO TOMBOLINI and FRANCESCA DE FELICE

In Vivo September 2022, 36 (5) 2521-2524; DOI: https://doi.org/10.21873/invivo.12988
You have access
Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma
HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, HAE JIN PARK, ME YEON LEE, AH RAM CHANG, SEMIE HONG and HOONSIK BAE

In Vivo March 2021, 35 (2) 1133-1139; DOI: https://doi.org/10.21873/invivo.12359
You have access
Prognostic Role of Lung Immune Scores for Prediction of Survival in Limited-stage Small Cell Lung Cancer
LEON SCHNÖLLER, LUKAS KÄSMANN, JULIAN TAUGNER, REEM ABDO, CHUKWUKA EZE and FARKHAD MANAPOV

In Vivo March 2021, 35 (2) 929-935; DOI: https://doi.org/10.21873/invivo.12333
You have access
Impact of Fluoropyrimidine and Oxaliplatin-based Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
YUKA OKADA, TSUYOSHI OZAWA, TAMURO HAYAMA, KOHEI OHNO, MITSUO TSUKAMOTO, YOSHIHISA FUKUSHIMA, RYU SHIMADA, KEIJIRO NOZAWA, KEIJI MATSUDA and YOJIRO HASHIGUCHI

In Vivo January 2021, 35 (1) 593-601; DOI: https://doi.org/10.21873/invivo.12296
You have access
Combining Radiomics and Blood Test Biomarkers to Predict the Response of Locally Advanced Rectal Cancer to Chemoradiation
SEUNG HYUCK JEON, CHANGHOON SONG, EUI KYU CHIE, BOHYOUNG KIM, YOUNG HOON KIM, WON CHANG, YOON JIN LEE, JOO-HYUN CHUNG, JIN BEOM CHUNG, KEUN-WOOK LEE, SUNG-BUM KANG and JAE-SUNG KIM

In Vivo September 2020, 34 (5) 2955-2965; DOI: https://doi.org/10.21873/invivo.12126
You have access
Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study
JOO HO LEE, BYUNG-HEE KANG, CHANGHOON SONG, SUNG-BUM KANG, HYE SEUNG LEE, KEUN-WOOK LEE, EUI KYU CHIE and JAE-SUNG KIM

In Vivo July 2020, 34 (4) 2119-2126; DOI: https://doi.org/10.21873/invivo.12017

Main menu

User menu

Search

chemoradiotherapy

Pages